Results 191 to 200 of about 273,161 (350)

HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients. [PDF]

Curr Microbiol
Cossu I, Ruberto S, Filippi E, Simula ER, Noli M, Mottula A, Fozza C, Sechi LA.   +7 more
europepmc   +1 more source

Epidemiology of Non-Hodgkin's Lymphoma in India

Oncology, 2016
R. Nair, N. Arora, M. Mallath
semanticscholar   +1 more source

Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders

British Journal of Haematology, EarlyView.
S. Ghorashian, R. Sanderson, J. Lee, A. Black, M. A. O'Reilly, D. I. Marks, J. Snowden, D. Richardson, E. Olavarria   +8 more
wiley   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Integrated Model for Predicting Cancer Therapy-Related Cardiac Dysfunction in Non-Hodgkin Lymphoma. [PDF]

Biomedicines
Bursacovschi D, Arnaut O, Ochisor V, Mihalache G, Baltaga R, Iacomi V, Robu M, Revenco V.   +7 more
europepmc   +1 more source

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Journal of Clinical Oncology, 2015
V. Minard-Colin, L. Brugières, A. Reiter, M. Cairo, T. Gross, W. Woessmann, B. Burkhardt, J. Sandlund, Denise Williams, M. Pillon, K. Horibe, A. Aupérin, M. le Deley, M. Zimmerman, S. Perkins, M. Raphael, L. Lamant, W. Klapper, L. Mussolin, H. Poirel, E. Macintyre, C. Damm-Welk, Angelo Rosolen, C. Patte   +23 more
semanticscholar   +1 more source

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Analysis of the efficacy and prognostic factors of gemcitabine combined with oxaliplatin in non-Hodgkin lymphoma. [PDF]

Oncol Lett
Zhang X, Li G, Liu F, Shi R, Wen J, Wu W, Dai J.   +6 more
europepmc   +1 more source

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma [PDF]

, 2017
Bianchi, Maurizio, Buffardi, Salvatore, Burnelli, Roberta, Caggiari, Laura, Carosella, Edgardo D., D'Amore, Emanuele Stefano, DE ZORZI, Mariangela, Elia, Caterina, Famengo, Barbara, Farruggia, Piero, Martina, Lia, Mascarin, Maurizio, Muggeo, Paola, Mussolin, Lara, Pillon, Marta, Re, Valli, Sala, Alessandra, Santoro, Nicola, Vinti, Luciana   +18 more
core   +1 more source

Transformed follicular non-Hodgkin lymphoma.

Blood, 2015
C. Casulo, W. R. Burack, J. Friedberg, J. Wilmot, Cancer Center   +4 more
semanticscholar   +1 more source